$3.71
▼ -8.4% Today
as of Oct 22, 16:48 ET
Last 30 days
Recent Press Releases & News
Evaxion stock surges on 3-year melanoma vaccine trial data
INTC, EVAX, RCAT Stocks Move Higher Premarket — What’s Driving The Rally?
Evaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01
EVAX earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±16.6% on average; after the most recent report on May 7, 2026 it moved -7.7%. EVAX beat the consensus EPS estimate in 1 of its last 2 reported quarters. The share price of $3.71 sits in the middle of its 52-week range.
Overview
52-week range
$2.72
$6.92
24% of range
Avg surprise (last 2)
+1.7%
Avg reaction (last 2)
+8.9%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.44 | — | — | -51.7% | -7.7% | earnings |
| Thu Nov 6, 2025 | Sep/2025 | $0.73 | — | — | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.76 | $-0.50 | -52.0% | — | — | earnings |
| Tue May 27, 2025 | Mar/2025 | $-0.29 | $-0.65 | +55.4% | — | +25.5% | earnings |
Implied volatility — last 90 days
No IV snapshots yet for EVAX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
EVAX earnings FAQ
How does EVAX stock usually react to earnings?
Across the last 2 reports the average next-day move was ±16.6%, up 1 times and down 1 times.